Who are PET Scan with [18F] VAT's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): [Ga-68]PSMA, 18F-rhPSMA-7.3, Florastamin[18F] Injection, 68Ga-PSMA-11, F-18 FPCIT, Fluoro-L-thymidine-(18F).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/pet-scan-with-18f-vat.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

PET Scan with [18F] VAT — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PET Scan with [18F] VAT (PET Scan with [18F] VAT) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: PET imaging agent / Radiopharmaceutical. Area: Diagnostic Imaging / Nuclear Medicine.

marketed PET imaging agent / Radiopharmaceutical Vascular adhesion molecules (VAM) Diagnostic Imaging / Nuclear Medicine Small molecule Live · refreshed every 30 min

Target snapshot

PET Scan with [18F] VAT (PET Scan with [18F] VAT) — Stony Brook University. [18F] VAT is a fluorine-18 labeled positron emission tomography (PET) imaging agent that binds to vascular adhesion molecules to visualize inflammation and vascular pathology.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
PET Scan with [18F] VAT TARGET	PET Scan with [18F] VAT	Stony Brook University	marketed	PET imaging agent / Radiopharmaceutical	Vascular adhesion molecules (VAM)
[Ga-68]PSMA	[Ga-68]PSMA	Norbert Avril, M.D.	marketed	PET imaging agent / radiopharmaceutical	PSMA (prostate-specific membrane antigen)
18F-rhPSMA-7.3	18F-rhPSMA-7.3	Hackensack Meridian Health	marketed	PET imaging agent / radiopharmaceutical	PSMA (prostate-specific membrane antigen)
Florastamin[18F] Injection	Florastamin[18F] Injection	HTA Co., Ltd.	phase 3	PET imaging agent / radiopharmaceutical
68Ga-PSMA-11	68Ga-PSMA-11	Weill Medical College of Cornell University	phase 3	PET imaging agent / radiopharmaceutical	PSMA (prostate-specific membrane antigen)
F-18 FPCIT	F-18 FPCIT	Asan Medical Center	phase 3	PET imaging agent / Radiopharmaceutical	Dopamine transporter (DAT)
Fluoro-L-thymidine-(18F)	Fluoro-L-thymidine-(18F)	Assistance Publique - Hôpitaux de Paris	phase 3	PET imaging agent / radiopharmaceutical	Thymidine kinase 1 (TK1)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (PET imaging agent / Radiopharmaceutical class)

Asan Medical Center · 1 drug in this class
First Affiliated Hospital of Zhejiang University · 1 drug in this class
Stony Brook University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). PET Scan with [18F] VAT — Competitive Intelligence Brief. https://druglandscape.com/ci/pet-scan-with-18f-vat. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab